Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Research Report 2019

Table of Contents

Executive Summary

1 Polyarticular Juvenile Idiopathic Arthritis Drug Market Overview

• 1.1 Product Overview and Scope of Polyarticular Juvenile Idiopathic Arthritis Drug
• 1.2 Polyarticular Juvenile Idiopathic Arthritis Drug Segment by Type
  • 1.2.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Etanercept Biosimilar
  • 1.2.3 Tocilizumab Biosimilar
  • 1.2.4 Sarilumab
  • 1.2.5 Adalimumab Biosimilar
  • 1.2.6 Others
• 1.3 Polyarticular Juvenile Idiopathic Arthritis Drug Segment by Application
  • 1.3.1 Polyarticular Juvenile Idiopathic Arthritis Drug Consumption Comparison by Application (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.3 Global Polyarticular Juvenile Idiopathic Arthritis Drug Market by Region
  • 1.3.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Size Region
  • 1.3.2 North America Status and Prospect (2014-2025)
  • 1.3.3 Europe Status and Prospect (2014-2025)
  • 1.3.4 China Status and Prospect (2014-2025)
  • 1.3.5 Japan Status and Prospect (2014-2025)
  • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
  • 1.3.7 India Status and Prospect (2014-2025)
• 1.4 Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Size
  • 1.4.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (2014-2025)
  • 1.4.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Production (2014-2025)

2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Competition by Manufacturers

• 2.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Polyarticular Juvenile Idiopathic Arthritis Drug Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites, Area Served, Product Types
• 2.5 Polyarticular Juvenile Idiopathic Arthritis Drug Market Competitive Situation and Trends
  • 2.5.1 Polyarticular Juvenile Idiopathic Arthritis Drug Market Concentration Rate
  • 2.5.2 Polyarticular Juvenile Idiopathic Arthritis Drug Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Polyarticular Juvenile Idiopathic Arthritis Drug Production Market Share by Regions

• 3.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Production Market Share by Regions
• 3.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share by Regions (2014-2019)
• 3.3 Global Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Polyarticular Juvenile Idiopathic Arthritis Drug Production
  • 3.4.1 North America Polyarticular Juvenile Idiopathic Arthritis Drug Production Growth Rate (2014-2019)
  • 3.4.2 North America Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Polyarticular Juvenile Idiopathic Arthritis Drug Production
  • 3.5.1 Europe Polyarticular Juvenile Idiopathic Arthritis Drug Production Growth Rate (2014-2019)
  • 3.5.2 Europe Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Polyarticular Juvenile Idiopathic Arthritis Drug Production (2014-2019)
  • 3.6.1 China Polyarticular Juvenile Idiopathic Arthritis Drug Production Growth Rate (2014-2019)
  • 3.6.2 China Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Polyarticular Juvenile Idiopathic Arthritis Drug Production (2014-2019)
  • 3.7.1 Japan Polyarticular Juvenile Idiopathic Arthritis Drug Production Growth Rate (2014-2019)
  • 3.7.2 Japan Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Polyarticular Juvenile Idiopathic Arthritis Drug Consumption by Regions

• 4.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Consumption by Regions
• 4.2 North America Polyarticular Juvenile Idiopathic Arthritis Drug Consumption (2014-2019)
• 4.3 Europe Polyarticular Juvenile Idiopathic Arthritis Drug Consumption (2014-2019)
• 4.4 China Polyarticular Juvenile Idiopathic Arthritis Drug Consumption (2014-2019)
• 4.5 Japan Polyarticular Juvenile Idiopathic Arthritis Drug Consumption (2014-2019)

5 Global Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue, Price Trend by Type

• 5.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Production Market Share by Type (2014-2019)
• 5.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share by Type (2014-2019)
• 5.3 Global Polyarticular Juvenile Idiopathic Arthritis Drug Price by Type (2014-2019)
• 5.4 Global Polyarticular Juvenile Idiopathic Arthritis Drug Production Growth by Type (2014-2019)

6 Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Analysis by Applications

• 6.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Consumption Market Share by Application (2014-2019)
• 6.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Polyarticular Juvenile Idiopathic Arthritis Drug Business

• 7.1 Biocon Ltd
  • 7.1.1 Biocon Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites and Area Served
  • 7.1.2 Polyarticular Juvenile Idiopathic Arthritis Drug Product Introduction, Application and Specification
  • 7.1.3 Biocon Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Coherus BioSciences Inc
  • 7.2.1 Coherus BioSciences Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites and Area Served
  • 7.2.2 Polyarticular Juvenile Idiopathic Arthritis Drug Product Introduction, Application and Specification
  • 7.2.3 Coherus BioSciences Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Livzon Pharmaceutical Group Inc
  • 7.3.1 Livzon Pharmaceutical Group Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites and Area Served
  • 7.3.2 Polyarticular Juvenile Idiopathic Arthritis Drug Product Introduction, Application and Specification
  • 7.3.3 Livzon Pharmaceutical Group Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Momenta Pharmaceuticals Inc
  • 7.4.1 Momenta Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites and Area Served
  • 7.4.2 Polyarticular Juvenile Idiopathic Arthritis Drug Product Introduction, Application and Specification
  • 7.4.3 Momenta Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Mycenax Biotech Inc
  • 7.5.1 Mycenax Biotech Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites and Area Served
  • 7.5.2 Polyarticular Juvenile Idiopathic Arthritis Drug Product Introduction, Application and Specification
  • 7.5.3 Mycenax Biotech Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Oncobiologics Inc
  • 7.6.1 Oncobiologics Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites and Area Served
  • 7.6.2 Polyarticular Juvenile Idiopathic Arthritis Drug Product Introduction, Application and Specification
  • 7.6.3 Oncobiologics Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Oncodesign SA
  • 7.7.1 Oncodesign SA Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites and Area Served
  • 7.7.2 Polyarticular Juvenile Idiopathic Arthritis Drug Product Introduction, Application and Specification
  • 7.7.3 Oncodesign SA Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Panacea Biotec Ltd
  • 7.8.1 Panacea Biotec Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites and Area Served
  • 7.8.2 Polyarticular Juvenile Idiopathic Arthritis Drug Product Introduction, Application and Specification
  • 7.8.3 Panacea Biotec Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Regeneron Pharmaceuticals Inc
  • 7.9.1 Regeneron Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites and Area Served
  • 7.9.2 Polyarticular Juvenile Idiopathic Arthritis Drug Product Introduction, Application and Specification
  • 7.9.3 Regeneron Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Sandoz International GmbH
  • 7.10.1 Sandoz International GmbH Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites and Area Served
  • 7.10.2 Polyarticular Juvenile Idiopathic Arthritis Drug Product Introduction, Application and Specification
  • 7.10.3 Sandoz International GmbH Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 UCB SA

8 Polyarticular Juvenile Idiopathic Arthritis Drug Manufacturing Cost Analysis

• 8.1 Polyarticular Juvenile Idiopathic Arthritis Drug Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Polyarticular Juvenile Idiopathic Arthritis Drug
• 8.4 Polyarticular Juvenile Idiopathic Arthritis Drug Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Polyarticular Juvenile Idiopathic Arthritis Drug Distributors List
• 9.3 Polyarticular Juvenile Idiopathic Arthritis Drug Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Forecast

• 11.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue Forecast
  • 11.1.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Polyarticular Juvenile Idiopathic Arthritis Drug Price and Trend Forecast (2019-2025)
• 11.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue Forecast (2019-2025)
• 11.3 Global Polyarticular Juvenile Idiopathic Arthritis Drug Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Polyarticular Juvenile Idiopathic Arthritis Drug Consumption Forecast (2019-2025)
  • 11.3.2 Europe Polyarticular Juvenile Idiopathic Arthritis Drug Consumption Forecast (2019-2025)
  • 11.3.3 China Polyarticular Juvenile Idiopathic Arthritis Drug Consumption Forecast (2019-2025)
  • 11.3.4 Japan Polyarticular Juvenile Idiopathic Arthritis Drug Consumption Forecast (2019-2025)
• 11.4 Global Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Polyarticular Juvenile Idiopathic Arthritis Drug Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List